JV
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Assessment of access and outcomes of kidney transplantation through the reforms of the Swiss organ allocation system | Frontiers in public health |  | 2025 | 118 | 112 | ||
| Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer | Science advances | | 2025 | 86 | 191 | ||
| Incidence and Risk Factors for Infection in Heart Transplant Recipients on Posttransplant Extracorporeal Membrane Oxygenation (ECMO) | Transplantation direct | | 2025 | 4 | 21 | ||
| Comparing variable and feature selection strategies for prediction - protocol of a simulation study in low-dimensional transplantation data | PloS one | | 2025 | 13 | 40 | ||
| Reintegration Into the Workforce After Kidney Transplantation Based on Urbanization Status in Switzerland | Kidney International Reports | | 2025 | 94 | 139 | ||
| Outcome of Patients Transplanted for C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis | Kidney international reports | | 2025 | 48 | 140 | ||
| Invasive Candida infections in solid organ transplant recipients between 2008 and 2020 | American Journal of Transplantation | | 2025 | 12 | 33 | ||
| Surgical site infections, risk factors, and outcomes after liver transplant | JAMA network open | | 2025 | 71 | 167 | ||
| Overall survival of recurrent/metastatic head & neck squamous cell carcinoma patients progressing after ≥ 1 line of systemic therapy, treated with MVX-ONCO-1, a novel, first in class cell encapsulation-based immunotherapy : results of SAKK 11/16, a phase IIa trial | Experimental hematology & oncology | | 2025 | 50 | 38 | ||
| A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors | Cancer research communications | | 2024 | 106 | 154 | ||
| Infectious disease events in people with HIV receiving kidney transplantation : Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study | BMC infectious diseases | | 2024 | 62 | 97 | ||
| Do infectious diseases after kidney retransplantation differ from those after first kidney transplantation ? | Open forum infectious diseases | | 2024 | 112 | 87 | ||
| Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients | Transplant international | | 2024 | 110 | 98 | ||
| BK polyomavirus serotype-specific antibody responses in blood donors and kidney transplant recipients with and without new-onset BK polyomavirus-DNAemia : A Swiss Transplant Cohort Study | American journal of transplantation | | 2024 | 45 | 82 | ||
| Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3) | The journal of infectious diseases | | 2024 | 517 | 480 | ||
| Surgical site infections after kidney transplantation are independently associated with graft loss | American journal of transplantation | | 2024 | 57 | 146 | ||
| Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species | Frontiers in medicine | | 2024 | 86 | 24 | ||
| Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation : a longitudinal retrospective multicenter study | Bone marrow transplantation | | 2024 | 78 | 59 | ||
| NK and T cell repertoire is established early after allogeneic HSCT and is profoundly imprinted by CMV reactivation | Blood advances | | 2024 | 112 | 62 | ||
| Néphrologie solidaire : la coopération Genève-Yaoundé | Revue médicale suisse | | 2023 | 83 | 225 | ||
| Vaccine-preventable infections among solid organ transplant recipients in Switzerland | JAMA network open | | 2023 | 134 | 141 | ||
| Donor-derived fulminant herpes simplex virus hepatitis after liver transplantation : Two cases and review of literature | Transplant infectious disease | | 2023 | 132 | 135 | ||
| Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study | Frontiers in immunology | | 2023 | 157 | 46 | ||
| CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantation | Leukemia & lymphoma | | 2023 | 74 | 65 | ||
| Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients : The STOP-FLU trial | Clinical infectious diseases | | 2023 | 104 | 101 | ||
| Clinical prediction model for prognosis in kidney transplant recipients (KIDMO) : study protocol | Diagnostic and prognostic research | | 2023 | 77 | 155 | ||
| An automated histological classification system for precision diagnostics of kidney allografts | Nature medicine |  | 2023 | 98 | 0 | ||
| Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical Trial | Clinical infectious diseases | | 2023 | 147 | 187 | ||
| Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2) | Open forum infectious diseases | | 2023 | 92 | 71 | ||
| Bacteremia During the First Year After Solid Organ Transplantation : An Epidemiological Update | Open forum infectious diseases | | 2023 | 125 | 97 | ||
| Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantation | Frontiers in immunology | | 2023 | 82 | 60 | ||
| Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2 : Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2) | Open forum infectious diseases | | 2023 | 140 | 86 | ||
| HLA variants and TCR diversity against SARS-CoV-2 in the pre-COVID-19 era | HLA | | 2023 | 104 | 84 | ||
| The impact of pre-transplant donor specific antibodies on the outcome of kidney transplantation – Data from the Swiss transplant cohort study | Frontiers in immunology | | 2022 | 187 | 87 | ||
| Personalized immunotherapy with encapsulated cell technology : Feasibility, safety and efficacy results from the first-in-human clinical trial in advanced relapsing solid tumors | ESMO Congress 2022 | | 2022 | 88 | 129 | ||
| Analysis of T cell Repertoire and Transcriptome Identifies Mechanisms of Regulatory T cell (Treg) Suppression of GvHD | Blood | | 2022 | 501 | 136 | ||
| Regulation of HLA class I expression by non-coding gene variations | PLOS genetics | | 2022 | 172 | 166 | ||
| A National Survey Comparing Patients' and Transplant Professionals' Research Priorities in the Swiss Transplant Cohort Study | Transplant international | | 2022 | 210 | 113 | ||
| Atopy as an independent predictor for long-term patient and graft survival after kidney transplantation | Frontiers in rheumatology & clinical immunology | | 2022 | 172 | 37 | ||
| Use of statins after liver transplantation is associated with improved survival: results of a nationwide study | Alimentary pharmacology & therapeutics | | 2022 | 149 | 188 | ||
| Antibody‐mediated rejection after kidney transplantation in children; therapy challenges and future potential treatments | Clinical transplantation | | 2022 | 133 | 744 | ||
| Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | | 2022 | 241 | 117 | ||
| Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive Analysis | Frontiers in immunology | | 2022 | 199 | 154 | ||
| Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation | Blood advances | | 2021 | 315 | 122 | ||
| Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study | PLOS ONE | | 2021 | 321 | 347 | ||
| Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018 | Antimicrobial resistance and infection control | | 2021 | 380 | 135 | ||
| Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients | Medical mycology | | 2021 | 358 | 1 | ||
| Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation | Leukemia | | 2020 | 402 | 296 | ||
| Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination | NPJ Vaccines | | 2020 | 477 | 138 | ||
| CD8+ T-Cell Repertoire in Human Leukocyte Antigen Class I-Mismatched Alloreactive Immune Response | Frontiers in Immunology | | 2020 | 235 | 181 | ||
| Immunologic clearance of a BK virus-associated metastatic renal allograft carcinoma | Transplantation | | 2020 | 345 | 333 | ||
| Preformed and de novo DSA are associated with T-cell-mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsy | Pediatric Transplantation | | 2020 | 408 | 2 | ||
| HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation | Blood | | 2020 | 358 | 0 | ||
| Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation | Journal of Clinical Oncology | | 2020 | 187 | 0 | ||
| Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study | Clinical Infectious Diseases | | 2020 | 342 | 207 | ||
| Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT | Human Immunology | | 2020 | 197 | 13 | ||
| Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study | The Lancet. Haematology | | 2020 | 272 | 0 | ||
| Peripheral donor specific antibodies are associated with histology and cellular subtypes in protocol liver biopsies of pediatric recipients | Transplantation | | 2020 | 371 | 183 | ||
| Natural Killer Cell Alloreactivity Against Human Induced Pluripotent Stem Cells and Their Neuronal Derivatives into Dopaminergic Neurons | Stem Cells and Development |  | 2020 | 310 | 1 | ||
| Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the disease | Rheumatology | | 2020 | 324 | 8 | ||
| Vitamin d status and risk of infections after liver transplantation in the swiss transplant cohort study | Transplant International | | 2019 | 549 | 0 | ||
| Management of allergy transfer upon solid organ transplantation | American Journal of Transplantation | | 2019 | 392 | 270 | ||
| High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation | Bone Marrow Transplantation | | 2019 | 456 | 142 | ||
| Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study | Transplant Infectious Disease | | 2018 | 590 | 0 | ||
| Endothelial chimerism and vascular sequestration protect pancreatic islet grafts from antibody-mediated rejection | Journal of Clinical Investigation | | 2018 | 468 | 190 | ||
| Identification of seven novel HLA class I and II alleles | HLA | | 2018 | 250 | 0 | ||
| Clinical and histological evolution after de novo donor-specific anti-human leukocyte antigen antibodies: a single centre retrospective study | BMC Nephrology | | 2018 | 551 | 204 | ||
| LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions | Journal of Clinical Investigation | | 2018 | 481 | 202 | ||
| Factors associated with immune hemolytic anemia after pediatric liver transplantation | Pediatric Transplantation | | 2018 | 381 | 1 | ||
| Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine | The Pharmacogenomics Journal | | 2018 | 659 | 330 | ||
| A Systematic Review and Meta-Analysis of HCV Clearance | Liver international | | 2017 | 601 | 1 | ||
| The HLA-B landscape of Africa: Signatures of pathogen-driven selection and molecular identification of candidate alleles to malaria protection | Molecular Ecology | | 2017 | 644 | 508 | ||
| Identification of 3 novel HLA-B alleles: B*08:173, B*18:72:03 and B*53:05:02 | HLA | | 2017 | 556 | 0 | ||
| Immunogenicity of anti-HLA antibodies in pancreas and islet transplantation | Cell transplantation | | 2016 | 553 | 3 | ||
| Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro | Transplantation direct | | 2016 | 689 | 493 | ||
| A significant effect of the killer cell immunoglobulin-like receptor ligand human leucocyte antigen-C on fibrosis progression in chronic C hepatitis with or without liver transplantation | Liver international | | 2016 | 562 | 1 | ||
| Identification of the novel HLA-B*07:261 allele | HLA | | 2016 | 540 | 0 | ||
| Felty's syndrome and hypofibrinogenemia: an unusual target for anti-cyclic citrullinated peptide antibodies? | Modern rheumatology | | 2015 | 689 | 0 | ||
| Kidney paired donation: a plea for a Swiss National Programme | Schweizerische medizinische Wochenschrift | | 2015 | 719 | 353 | ||
| Atypical Hemolytic Uremic Syndrome Recurrence after Renal Transplantation: C3-Glomerulonephritis as an Initial Presentation | Transplantation direct | | 2015 | 511 | 2 | ||
| Restoration of hematopoiesis in a case of myelodysplastic syndrome associated with systemic lupus erythematosus treated with rituximab | Annals of hematology | | 2015 | 609 | 2 | ||
| Long-term follow-up of cadaveric breast augmentation: what can we learn? | Aesthetic surgery journal | | 2015 | 635 | 2 | ||
| Very Long Term Stability of Mixed Chimerism after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies | Bone marrow research | | 2015 | 583 | 148 | ||
| Protection From Varicella Zoster in Solid Organ Transplant Recipients Carrying Killer Cell Immunoglobulin-Like Receptor B Haplotypes | Transplantation | | 2015 | 541 | 0 | ||
| Potential and limitation of HLA-based banking of human pluripotent stem cells for cell therapy | Journal of immunology research | | 2014 | 512 | 0 | ||
| Prédispositions génétiques dans l'allergie médicamenteuse : importance du HLA | Revue médicale suisse | | 2014 | 519 | 0 | ||
| KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients | Genes and immunity | | 2014 | 676 | 0 | ||
| Expression of killer cell immunoglobulin-like receptors (KIRs) by natural killer cells during acute CMV infection after kidney transplantation | Transplant immunology | | 2014 | 695 | 2 | ||
| Interaction of ES cell derived neural progenitor cells with natural killer cells and cytotoxic T cells | Methods in molecular biology | | 2013 | 661 | 2 | ||
| The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in children | PloS one | | 2013 | 725 | 406 | ||
| Transplanted human pancreatic islets after long-term insulin independence | American journal of transplantation | | 2013 | 869 | 1 | ||
| The role of immunosuppression in the transplantation of allogenic neural precursors derived from human pluripotent stem cells for Parkinson's disease | Stem cell research & therapy | | 2013 | 999 | 334 | ||
| Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy | Leukemia | | 2012 | 1,266 | 637 | ||
| HLA and non-HLA polymorphisms in renal transplantation | Schweizerische medizinische Wochenschrift | | 2012 | 662 | 1 | ||
| Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation | Pediatric transplantation | | 2012 | 726 | 0 | ||
| Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations | Stem cells and development | | 2012 | 690 | 808 | ||
| Posttransplant cellular immune reactivity against donor antigen correlates with clinical islet transplantation outcome: towards a better posttransplant monitoring | Cell transplantation | | 2012 | 612 | 0 | ||
| Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients | HIV medicine | | 2012 | 724 | 0 | ||
| Detection of anti-HLA antibodies by solid-phase assay in kidney transplantation: friend or foe? | Tissue antigens | | 2012 | 701 | 0 | ||
| Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients | Haematologica | | 2011 | 1,052 | 621 | ||
| Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipients | Clinical journal of the American Society of Nephrology | | 2011 | 616 | 0 | ||
| Introduction: Immunopathology and the promise of stem cell research | Seminars in immunopathology | | 2011 | 647 | 143 | ||
| Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study | Arthritis and rheumatism | | 2011 | 878 | 8 | ||
| Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation | American journal of transplantation | | 2011 | 746 | 0 | ||
| Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activity | Cell transplantation | | 2011 | 701 | 0 | ||
| De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients | American journal of transplantation | | 2011 | 666 | 0 | ||
| How to cross immunogenetic hurdles to human embryonic stem cell transplantation | Seminars in immunopathology | | 2011 | 630 | 349 | ||
| The role of natural killer cells in human solid organ and tissue transplantation | Journal of innate immunity | | 2011 | 578 | 0 | ||
| Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation | Transplantation | | 2010 | 658 | 0 | ||
| Early relapse of autoimmune glomerulonephritis after kidney transplantation despite antibody induction and triple-drug-based immunosuppression | Transplantation | | 2010 | 654 | 0 | ||
| Natural killer cell receptor--repertoire and functions after induction therapy by polyclonal rabbit anti-thymocyte globulin in unsensitized kidney transplant recipients | Clinical immunology | | 2010 | 648 | 0 | ||
| The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation | The Journal of immunology | | 2009 | 713 | 0 | ||
| Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells | Journal of Cellular and Molecular Medicine | | 2009 | 607 | 152 | ||
| Humoral and cellular rejection after combined liver-kidney transplantation in low immunologic risk recipients | Transplant international | | 2009 | 644 | 0 | ||
| Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: over the 10-year mark | American journal of transplantation | | 2009 | 978 | 6 | ||
| Sequence of a novel HLA-A2 allele in a haematopoietic stem cell donor of the international registry | Tissue antigens | | 2009 | 633 | 0 | ||
| Pluripotent stem cells as new drugs? The example of Parkinson's disease | International journal of pharmaceutics | | 2009 | 781 | 3 | ||
| A new HLA-DR4 allele, DRB1*0474, with an unusual residue at position 77 | Tissue antigens | | 2008 | 640 | 1 | ||
| Low risk of anti-human leukocyte antigen antibody sensitization after combined kidney and islet transplantation | Transplantation | | 2008 | 925 | 0 | ||
| Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation | American journal of transplantation | | 2008 | 772 | 0 | ||
| IL-21 promotes survival and maintains a naive phenotype in human CD4+ T lymphocytes | International immunology | | 2008 | 575 | 164 | ||
| DNA typing by microbead arrays and PCR-SSP: apparent false-negative or -positive hybridization or amplification signals disclose new HLA-B and -DRB1 alleles | Tissue antigens | | 2008 | 584 | 0 | ||
| Human herpesvirus-6 variant A encephalomyelitis | Neurology | | 2008 | 673 | 0 | ||
| The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors | Arthritis Research and Therapy | | 2007 | 238 | 167 | ||
| Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab | Transplant international | | 2007 | 851 | 0 | ||
| Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine | Experimental Hematology | | 2007 | 198 | 0 | ||
| Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance | Antimicrobial Agents and Chemotherapy | | 2007 | 267 | 0 | ||
| Investigation of alloreactive NK cells in mixed lymphocyte reactions using paraformaldehyde-silenced target cells | Journal of Immunological Methods | | 2007 | 201 | 0 | ||
| Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications | Blood | | 2006 | 636 | 0 | ||
| Anti-HLA antibody repertoire after IVIg infusion in highly sensitized patients waiting for kidney transplantation | Schweizerische medizinische Wochenschrift | | 2006 | 528 | 355 | ||
| Acute humoral rejection in kidney allograft following a third-party arterial transplantation | American journal of transplantation | | 2006 | 632 | 0 | ||
| Differentiation between atypical isolates of Candida lusitaniae and Candida pulcherrima by determination of mating type | Journal of Clinical Microbiology | | 2005 | 212 | 0 | ||
| Microchimerism after liver transplantation: absence of rejection without abrogation of anti-donor cytotoxic T-lymphocyte-mediated alloreactivity | Liver transplantation | | 2005 | 544 | 480 | ||
| Pseudovasculitis and corticosteroid therapy | Clinical rheumatology | | 2005 | 579 | 253 | ||
| Inactivation of the FCY2 gene encoding purine-cytosine permease promotes cross-resistance to flucytosine and fluconazole in Candida lusitaniae | Antimicrobial Agents and Chemotherapy | | 2005 | 199 | 139 | ||
| Development of an integrative transformation system for the opportunistic pathogenic yeast Candida lusitaniae using URA3 as a selection marker | Yeast | | 2004 | 176 | 0 | ||
| Cellular and Gene Therapy for Major Histocompatibility Complex Class II Deficiency | News in physiological sciences | | 2004 | 107 | 0 | ||
| A new DR7-DQ8 haplotype resulting from a recombination between the DQA1 and DQB1 loci in a leukemic patient of Caucasoid origin | Immunogenetics | | 2004 | 251 | 0 | ||
| Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes | European Journal of Immunology | | 2004 | 263 | 213 | ||
| Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors | Blood | | 2003 | 303 | 260 | ||
| Flucytosine-fluconazole cross-resistance in purine-cytosine permease-deficient Candida lusitaniae clinical isolates: indirect evidence of a fluconazole uptake transporter | Antimicrobial Agents and Chemotherapy | | 2003 | 190 | 214 | ||
| Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency | Molecular therapy | | 2002 | 639 | 0 | ||
| Selection of unrelated bone marrow donors by serology, molecular typing and cellular assays | Transplant Immunology | | 2002 | 158 | 0 | ||
| Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP | Molecular and cellular biology | | 2001 | 527 | 0 | ||
| A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y | Molecular and cellular biology | | 2000 | 660 | 0 | ||
| Dissection of functional NF-Y-RFX cooperative interactions on the MHC class II Ea promoter | Journal of Molecular Biology | | 2000 | 661 | 0 | ||
| Molecular genetics of the Bare lymphocyte syndrome | Reviews in immunogenetics | 2000 | 568 | 0 | |||
| Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression | Immunological reviews | | 2000 | 665 | 0 | ||
| CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex | Genes & development | | 2000 | 484 | 0 | ||
| The molecular basis of MHC class II deficiency and transcriptional control of MHC class II gene expression | Microbes and infection | | 1999 | 593 | 0 | ||
| CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes | International immunology | | 1999 | 603 | 0 | ||
| Genetic and molecular definition of complementation group D in MHC class II deficiency | Human molecular genetics | | 1998 | 632 | 0 | ||
| MHC class II deficiency: definition of a new complementation group | Immunobiology | 1997 | 617 | 0 | |||
| Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiency | Human mutation | | 1997 | 618 | 0 | ||
| Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency | The New England journal of medicine | | 1997 | 639 | 0 |
